刺激反应性STING纳米疫苗用于HPV诱导癌症的全身治疗
Shuang Chen1,2, Shuyue Ye1,2, Gang Huang1,2
1Department of Biomedical Engineering, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
概括
一种新型纳米疫苗激活了STING通路,以增强T细胞对人类乳头瘤病毒 (HPV) 诱导的癌症的免疫力. 这种对刺激有反应的设计可以改善抗瘤反应,同时最大限度地降低全身毒性,从而有效治疗癌症.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 治疗性癌症疫苗旨在增强T细胞反应,但在免疫激活和抗原递送方面面临挑战.
- 干扰素基因刺激剂 (STING) 激动剂表现有前途,但系统性管理导致毒性和有效性有限.
- 人类乳头瘤病毒 (HPV) 诱导的癌症代表了对有效免疫疗法的重大未满足的医疗需求.
研究的目的:
- 开发一种对刺激有反应的STING纳米疫苗,用于治疗HPV诱导的癌症.
- 为了改善抗原和STING激动剂向免疫细胞的传递.
- 增强抗瘤免疫力,同时降低全身毒性.
主要方法:
- 通过阿佐链接器将二胺基胺醇 (di-amidobenzimidazoles) (diABZI) 与激活STING的聚合物 (PSC7A) 结合,使用HPV16 E7蛋白作为抗原.
- 一种对酸性pH和NAD(P) H子氧化还原酶1 (NQO1) 反应的纳米疫苗的设计.
- 在临床前癌症模型 (TC-1和MLM3) 中纳米疫苗的静脉注射.
主要成果:
- 纳米疫苗 (25-30纳米) 有效地将E7蛋白和STING激动剂与淋巴体器官和瘤中的髓状细胞配合输送.
- 摄入PSC7A诱导了NQO1表达,加速了DABZI裂变和STING激活.
- 证明了E7特定的CD8+T细胞的强有力的产生,导致显著的瘤回归和减少全身毒性.
结论:
- 开发的刺激反应性STING纳米疫苗通过增强抗原特异性T细胞免疫力,有效治疗HPV诱导的癌症.
- 这种纳米疫苗设计克服了系统性STING激动剂的局限性,提供了更好的疗效和安全性.
- 这些发现突出了开发下一代癌症免疫疗法的有希望的战略.
相关概念视频
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


